Authors:
WEISS GR
POGGESI I
ROCCHETTI M
DEMARIA D
MOONEYHAM T
REILLY D
VITEK LV
WHALEY F
PATRICIA E
VONHOFF DD
ODWYER P
Citation: Gr. Weiss et al., A PHASE-I AND PHARMACOKINETIC STUDY OF TALLIMUSTINE [PNU152241 (FCE-24517)] IN PATIENTS WITH ADVANCED CANCER, Clinical cancer research, 4(1), 1998, pp. 53-59
Authors:
WEISS GR
POGGESI I
ROCCHETTI M
DEMARIA D
MOONEYHAM T
REILLY D
VITEK LV
WHALEY F
PATRICIA E
VONHOFF DD
ODWYER P
Citation: Gr. Weiss et al., A PHASE-I AND PHARMACOKINETIC STUDY OF TALLIMUSTINE [PNU152241 (FCE-24517)] IN PATIENTS WITH ADVANCED CANCER, Clinical cancer research, 4(1), 1998, pp. 53-59
Authors:
JONES S
VOGEL C
FEHRENBACHER L
EISENBERG P
ARKHIPOV A
TIFFANY J
POLLI A
WHALEY F
DISALLE E
MILLER L
Citation: S. Jones et al., A PHASE-II STUDY OF ANTITUMOR EFFICACY AND SAFETY OF EXEMESTANE (EXE)AS 3RD-LINE HORMONAL TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER (MBC) REFRACTORY TO TAMOXIFEN AND MEGACE(TM), Annals of oncology, 9, 1998, pp. 64-64
Citation: M. Stevens et al., DRUG-USE PREVALENCE IN A RURAL SCHOOL-AGE POPULATION - THE NEW-HAMPSHIRE SURVEY, American journal of preventive medicine, 11(2), 1995, pp. 105-113